No Data
No Data
Market Sentiment Around Loss-Making Zai Lab Limited (NASDAQ:ZLAB)
Trump Told Advisers He Wants to Visit China as President
GF SEC: VERTEX JPM meeting update, focusing on the progress in the fields of domestic enterprise pain and kidney disease.
The success of Suzetrigine offers hope for the development of the Nav1.8 target, and based on its inherent mechanism advantages, it is expected to bring a new, safer, and more effective therapy for pain patients.
Sector Update: Health Care Stocks Decline Late Afternoon
Zai Lab Announces China's NMPA Accepted NDA for KarXT
Zai Lab Limited's (NASDAQ:ZLAB) One-year Returns Climbed After Last Week's 4.4% Gain, Institutional Investors Must Be Happy